IP Library Granted Patent US 8,190,271
Granted Patent B2
US 8,190,271 · App. 12/202,134 · Granted May 29, 2012

Minimizing trauma during and after insertion of a cochlear lead

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,190,271
App. No.
12/202,134
Granted
May 29, 2012
Kind
B2
Abstract

A method for delivering dexamethasone base (DXMb) via an implantable electrode includes coupling DXMb to the implantable electrode and inserting the implantable electrode into animal tissue, the DXMb eluting into the animal tissue. An implantable nerve stimulating device includes an elongated member having a distal end bearing at least one electrode; and DXMb coupled to the elongated member, the DXMb being eluted into tissue surrounding the elongated member.

Claims (19)

1. A method for delivering dexamethasone base (DXMb) via an implantable electrode comprising:

coupling said DXMb and dexamethasone (DEX) salt to said implantable electrode by:

coating said implantable electrode with a layer of DXMb,

overcoating said layer of DXMb with a hydrophilic lubricant, and

applying a solution containing said DEX salt to said lubricant by soaking said implantable electrode in a solution containing DEX salt prior to use said solution being absorbed by said lubricant; and

inserting said implantable electrode into biological tissue, said DXMb and said DEX salt eluting into said biological tissue, wherein said DEX salt is configured to rapidly elute into said biological tissue and said DXMb is configured to more slowly elute into said biological tissue at a lower concentration than said DEX salt.

2. The method of claim 1 , wherein, said implantable electrode is configured to be inserted into a cochlea.

3. The method of claim 1 , wherein said lubricant comprises a slippery when wet lubricant.

4. A method for delivering dexamethasone base (DXMb) via an implantable electrode comprising:

coupling said DXMb to said implantable electrode by coating said implantable electrode with a layer of DXMb;

overcoating said layer of DXMb with a hydrophilic lubrication layer;

applying a solution containing dexamethasone (DEX) salt to said lubrication layer, said solution being absorbed by said lubrication layer; and

inserting said implantable electrode into biological tissue, said DXMb eluting into said biological tissue.

5. The method of claim 4 , wherein said lubrication layer comprises a slippery when wet lubricant.

6. An implantable nerve stimulating device comprising:

an elongated member having a distal end bearing at least one electrode; and

DXMb coupled to said elongated member;

DEX salt deposited over said DXMb;

wherein said DEX salt is configured to rapidly elute into surrounding tissue when the device is implanted and said DXMb is configured to more slowly elute into said surrounding tissue at a lower concentration than the DEX salt.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 16, 2019
From: ADVANCED BIONICS, LLC
To: ADVANCED BIONICS AG
Reel/Frame 050737/0269 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 12, 2008
From: COLVIN, MICHAEL S.; FALTYS, MICHAEL A.; OVERSTREET, EDWARD H.; XIE, JIAN
To: ADVANCED BIONICS, LLC
Reel/Frame 021521/0818 →